Source: Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helen K. Reddel, Jørgen Vestbo, Alvar Agustí, Gary P. Anderson, Aruna T. Bansal, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Ian D. Pavord, David Price, Eleni Rapsomaniki, Niklas Karlsson, Donna K. Finch, Javier Nuevo, Alex de Giorgio-Miller, Marianna Alacqua, Rod Hughes, Hana Müllerová, Maria Gerhardsson de Verdier. Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020

Member's Comments

No comment yet.

Related content which might interest you: Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Factors associated with exacerbations in patients with COPD: NOVELTY study Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study Source: International Congress 2017 – Asthma management Year: 2017 Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Incidence of asthma and COPD in a general population Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Defining asthma–COPD overlap syndrome: a population-based study Source: Eur Respir J, 49 (5) 1602008; 10.1183/13993003.02008-2016 Year: 2017 Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Risk of bronchiectasis in bronchial asthma: steroid-dependent versus non-steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005 Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Factors associated with physician assessment of severity of asthma or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Incidence of COPD and asthma overlap Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Passive smoking, asthma and asthma severity in the EGEA study Source: Eur Respir J 2001; 18: Suppl. 33, 373s Year: 2001 Exacerbation burden in mild asthma: Evidence from the NOVELTY study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Are doctor-diagnosed asthma and doctor-observed wheeze the same? Source: Eur Respir J 2003; 22: Suppl. 45, 387s Year: 2003 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Determinants of incident asthma-COPD overlap compared to asthma and COPD alone: A prospective study of 55,110 middle-aged adults Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017 Impact of chronic cough in individuals with COPD: a population-based cohort study Source: International Congress 2019 – More and more COPD Year: 2019